Early detection and interception of diffuse and intestinal gastric cancer, with Dr. Andrew Chan

On Day 2 of the Gastric Cancer Summit, moderated by Dr. Shailja Shah (UCSD) and Dr. Robert Huang (Stanford University), featured Dr. Andrew Chan presenting "LINE-1/ORF1p for the Early Detection of Gastric Cancer." Dr. Chan explored the role of LINE-1 and its associated protein ORF1p as a promising biomarker for the early detection of gastric cancer, discussing its potential in identifying patients at high risk and improving early diagnosis strategies.